A phase I/II study of lenvatinib (LEN) plus everolimus (EVE) in recurrent and refractory pediatric solid tumors, including CNS tumors.

被引：0
|
作者：
Dela Cruz, Filemon S.
Fox, Elizabeth
Muscal, Jodi Ann
Kirov, Ivan
Geller, James I.
DuBois, Steven G.
Kim, AeRang
Croop, James
Laetsch, Theodore Willis
Minard, Charles G.
Liu, Xiaowei
Weigel, Brenda
Okpara, Chinyere E.
Huang, Jie
Dutta, Lea
Aluri, Jagadeesh
Bender, Julia Lynne Glade
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA
[3] Baylor Coll Med, Houston, TX 77030 USA
[4] CHOC Childrens Hosp, Orange, CA USA
[5] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[6] Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA USA
[7] Harvard Med Sch, Boston, MA 02115 USA
[8] Childrens Natl Hosp, Washington, DC USA
[9] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
[10] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[11] Childrens Hlth, Dallas, TX USA
[12] Childrens Oncol Grp, Monrovia, CA USA
[13] Univ Minnesota, Minneapolis, MN USA
[14] Eisai Ltd, Hatfield, Herts, England
[15] Eisai Inc, Woodcliff Lake, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10527
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumors.
    Meany, Holly Jane
    Dome, Jeffrey
    Hinds, Pamela S.
    Bagatell, Rochelle
    Shusterman, Suzanne
    Widemann, Brigitte C.
    Stern, Emily
    London, Wendy B.
    Kim, AeRang
    Fox, Elizabeth
    Rodriguez-Galindo, Carlos
    Minturn, Jane E.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [42] A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors
    Becher, Oren J.
    Gilheeney, Stephen W.
    Khakoo, Yasmin
    Lyden, David C.
    Haque, Sofia
    De Braganca, Kevin C.
    Kolesar, Jill M.
    Huse, Jason T.
    Modak, Shakeel
    Wexler, Leonard H.
    Kramer, Kim
    Spasojevic, Ivan
    Dunkel, Ira J.
    PEDIATRIC BLOOD & CANCER, 2017, 64 (07)
  • [43] A phase I/II study of regorafenib (R) plus avelumab (A) in digestive tumors.
    Cousin, Sophie
    Toulmonde, Maud
    Albert, Sabrina
    Bellera, Carine A.
    Lortal, Barbara
    Mathoulin-Pelissier, Simone
    Italiano, Antoine
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [44] Phase I study of tamibarotene monotherapy in pediatric and young adult patients with recurrent/refractory solid tumors
    Nitani, Chika
    Hara, Junichi
    Kawamoto, Hiroshi
    Taguchi, Tomoaki
    Kimura, Toshimi
    Yoshimura, Kenichi
    Hamada, Akinobu
    Kitano, Shigehisa
    Hattori, Naoko
    Ushijima, Toshikazu
    Ono, Hiromi
    Nakamoto, Masako
    Higuchi, Tsukiko
    Sato, Akihiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 88 (01) : 99 - 107
  • [45] Phase I study of tamibarotene monotherapy in pediatric and young adult patients with recurrent/refractory solid tumors
    Chika Nitani
    Junichi Hara
    Hiroshi Kawamoto
    Tomoaki Taguchi
    Toshimi Kimura
    Kenichi Yoshimura
    Akinobu Hamada
    Shigehisa Kitano
    Naoko Hattori
    Toshikazu Ushijima
    Hiromi Ono
    Masako Nakamoto
    Tsukiko Higuchi
    Akihiro Sato
    Cancer Chemotherapy and Pharmacology, 2021, 88 : 99 - 107
  • [46] A phase I study of cabozantinib (XL184) in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: A Children's Oncology Group phase I consortium trial.
    Chuk, Meredith K.
    Widemann, Brigitte C.
    Ahern, Charlotte H.
    Reid, Joel M.
    Kim, AeRang
    Wright, John Joseph
    Lodish, Maya
    Fox, Elizabeth
    Weigel, Brenda
    Blaney, Susan
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [47] A phase II study of pazopanib in children, adolescents, and young adults with refractory solid tumors.
    Lee, Alice
    Bender, Julia Glade
    Weigel, Brenda
    Fox, Elizabeth
    Huff, Anne C.
    Tada, Hiroomi
    Blaney, Susan M.
    Langmuir, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [48] A phase I study of metformin and chemotherapy in solid tumors.
    Kritharis, Athena
    Caplain, Jennifer
    Rajagopal, Shrikar
    Grimm, Elizabeth
    Tsichlis, Philip N.
    Martell, Robert
    Saif, Waslf M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [49] Phase I and pharmacokinetic study of farletuzumab in solid tumors.
    Sasaki, Yasutsuna
    Miwa, Keisuke
    Yamashita, Keishi
    Fujiwara, Keiichi
    Katsumata, Noriyuki
    Fujiwara, Yasuhiro
    Namiki, Masayuki
    Koyanagi, Nozomu
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [50] PHASE I AND PHARMACOKINETIC TRIAL OF PTC299 IN PEDIATRIC PATIENTS WITH REFRACTORY OR RECURRENT CNS TUMORS: A PBTC STUDY
    Packer, Roger J.
    Rood, Brian R.
    Onar-Thomas, Arzu
    Goldman, Stewart
    Fisher, Michael J.
    Smith, Christopher
    Boyett, James
    Kun, Larry
    NEURO-ONCOLOGY, 2012, 14 : 112 - 112
12345